Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +50.0% | +49.6% | 2 / 3 | +6.1% | +1.61 pp | +1.56 pp | +36.2% | 3.55 | 6.05 | 592 | +6,1% | 31,7 | +49,7% | 6.05 | 8.38 | −27,8% |
| Pts | 8 | 12 | 8 | 0 | 8 | 8 | 12 | -4 | 12 | |||||||
Valuation annotation:Price: 11.750 (close price on 2026-10-19)EPS (TTM): 1.941
Financial charts
1.Revenue & growth
VND bn592Q2/26
1.Revenue & growth
VND bn592Q2/26
2.Profit & growth
VND bn31,1Q2/26
3.Profit mix (Penman)
VND bn71,5Q2/26
4.Margins & cost structure
%12.3%Q2/26
5.Returns & cash cycle
% · days18.8%Q2/26
6.Earnings quality & cash
VND bn-329Q2/26
7.Asset structure
VND bn2.156Q2/26
8.Funding & debt health
VND bn · times2.156Q2/26
9.Revenue backlog
VND bn65,2Q2/26
10.Valuation
times · %6,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %833Q2/26
Adjusted EPS growth, latest quarter
46.8%
Average adjusted EPS growth, 3 quarters
20.6%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26